Early Outcomes for Management of Atrioventricular Septal Defect—Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons’ Society Study
BackgroundWe sought to determine the management and early outcomes of complete atrioventricular septal defect-tetralogy of Fallot (AVSD-TOF) for a contemporary multicenter cohort.MethodsOf 739 participants in the Congenital Heart Surgeons' Society AVSD cohort (January 2012-May 2021), 40 had AVSD-TOF. We first compared survival differences for patients with AVSD-TOF versus those with isolated AVSD using propensity matching. Secondly, for patients with AVSD-TOF, we compared staged (n = 16) versus primary (n = 24) repair by assessing the following: patient characteristics, progression of atrioventricular valve (AVV) regurgitation, and time-related reoperation and survival.ResultsFive-year survival was similar between matched AVSD-TOF and isolated AVSD groups (80% vs 81%, <i>P</i> = .9). Compared with primary repair patients, staged patients had smaller pulmonary valve annulus Z-score measured at first presentation (-2.2 vs -2.9, <i>P</i> = .006). All staged patients (12 Blalock-Thomas-Taussig shunts, 3 right-ventricular-outflow-tract stents, 1 ductal stent) survived to complete repair. Freedom from AVSD-related reoperation five years post-AVSD-TOF repair was 57% after staged versus 90% after primary repair (<i>P</i> < .05) and left AVV reoperations were the most frequent reintervention. Survival five years after AVSD-TOF repair was 80% (63% after staged vs 90% after primary repair; <i>P</i> = .08).ConclusionsPatients undergoing AVSD-TOF repair have similar survival compared with matched isolated AVSD patients. Although approximately half of AVSD-TOF patients had initial palliation and all survived to complete repair, staged repair patients had lower survival and a higher reintervention rate compared with primary repair patients. The decision to pursue staged versus primary repair for future babies with AVSD-TOF remains challenging and should be chosen based on individual circumstances.
Authors
- Connor P. Callahan
- Robert J. Dabal
- Anusha Jegatheeswaran (ORCID: https://orcid.org/0009-0009-7586-7526)
- William M. DeCampli (ORCID: https://orcid.org/0000-0001-6254-225X)
- Anastasios C. Polimenakos (ORCID: https://orcid.org/0000-0003-0981-2315)
- Joseph William Turek (ORCID: https://orcid.org/0000-0002-4006-7555)
- Pirooz Eghtesady (ORCID: https://orcid.org/0000-0001-7161-8391)
- James K. Kirklin (ORCID: https://orcid.org/0000-0002-7861-3267)
- David M. Overman (ORCID: https://orcid.org/0000-0002-4321-9382)
- David J. Barron (ORCID: https://orcid.org/0000-0002-3671-5337)
- Madison B. Argo (ORCID: https://orcid.org/0000-0001-6026-2203)
- Osami Honjo
- Brian W. McCrindle
Institutions
- St. Louis Children's Hospital (US)
- Washington University in St. Louis (US)
- Augusta University (US)
- UW Health University Hospital (US)
- Great Ormond Street Hospital (GB)
- Arnold Palmer Hospital for Children (US)
- Hospital for Sick Children (CA)
- University of Alabama at Birmingham (US)
- Duke Children's Hospital & Health Center (US)
- University College London (GB)
Publication Details
- Journal
- World Journal for Pediatric and Congenital Heart Surgery
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1177/21501351241293158
- Citations
- 1
- Primary Topic
- Congenital Heart Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39